SPC
MRK icon

Spirepoint Private Client’s Merck MRK Stock Holding History

Spirepoint Private Client’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
11,531
+179
+2% +$20.7K 0.13% 103
2025
Q4 		$1.19M Buy
11,352
+358
+3% +$33.6K 0.11% 106
2025
Q3 		$923K Sell
10,994
-64,872
-86% -$5.34M 0.1% 122
2025
Q2 		$6.01M Buy
75,866
+14
+0% +$1.11K 0.68% 44
2025
Q1 		$6.81M Buy
75,852
+7,409
+11% +$692K 0.89% 39
2024
Q4 		$6.81M Buy
68,443
+46,406
+211% +$4.78M 0.85% 32
2024
Q3 		$2.5M Sell
22,037
-37
-0.2% -$4.4K 0.33% 65
2024
Q2 		$2.73M Sell
22,074
-72
-0.3% -$9.27K 0.39% 57
2024
Q1 		$2.92M Buy
+22,146
New +$2.73M 0.45% 48

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spirepoint Private Client's MRK Position: Q1 2026 in Review

Spirepoint Private Client increased its Merck (MRK) stake by 1.6% in Q1 2026, buying an estimated $20.7K and bringing the position to 11,531 shares worth $1.39M. The position accounts for 0.13% of the portfolio, ranked #103.

Spirepoint Private Client first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.81M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Spirepoint Private Client held 11,531 shares of Merck worth $1.39M as of Q1 2026.
  • Spirepoint Private Client bought 179 Merck shares in Q1 2026, an estimated $20.7K.
  • Merck made up 0.13% of Spirepoint Private Client's portfolio in Q1 2026, its #103 holding.
  • Spirepoint Private Client first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Spirepoint Private Client's Merck position peaked at $6.81M in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.